Position history for UBS Group AG's holdings in AMNEAL PHARMACEUTICALS INC
UBS Group AG holds 840,958 shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $10.5M as of 2026-Q1. The position was decreased (-10.1% shares). AMRX represents 0.0% of UBS Group AG's portfolio.
Current Value
$10.5M
Current Shares
840,958
Total Value Change
-$128.3M
Total Shares Change
-21M
Other major holders of AMRX: BlackRock, Inc., VANGUARD GROUP INC
Decreased |
| 840,958 |
-10.1% |
| $10.5M |
| 0.0% |
| $13.31 |
0 |
| 2025-Q4 | Decreased | 935,479 | -35.3% | $11.8M | 0.0% | $12.88 | 0 |
| 2025-Q3 | Decreased | 1.4M | -8.7% | $14.5M | 0.0% | $9.87 | 0 |
| 2025-Q2 | Decreased | 1.6M | -12.7% | $12.8M | 0.0% | $8.13 | 0 |
| 2025-Q1 | Increased | 1.8M | +8.8% | $15.2M | 0.0% | $8.28 | 31 |
| 2024-Q4 | Decreased | 1.7M | -92.3% | $13.2M | 0.0% | $7.83 | 0 |
| 2024-Q3 | Decreased | 21.8M | -0.3% | $181.2M | 0.0% | $8.19 | 0 |
| 2024-Q2 | Increased | 21.8M | +122x | $138.7M | 0.0% | $6.35 | 49 |